Search results
Silence Therapeutics’ Divesiran Hits Phase II Goal, Sets Up Phase III PV Trial
Key Points
- Interested in Silence Therapeutics PLC Sponsored ADR? Here are five stocks we like better.
- Divesiran met the Phase II SANRECO primary endpoint in phlebotomy-dependent polycythemia
Seagate Technology Stock Surges as Earnings Beat Silences AI Doubters
Key Points
- Interested in Seagate Technology Holdings PLC? Here are five stocks we like better.
- Seagate’s earnings report showed that AI-driven storage demand remains strong despite the stock’s